Prime Minister Carney expands Canada’s partnership with Ireland across science, technology, and culture
Publish Date: 2026-06-14 12:53:00
Source Domain: www.pm.gc.ca
In a more dangerous and divided world, Canada is building our strength at home and diversifying our partnerships abroad. Our European allies are central to this mission, as we share history, values, and – increasingly – shared interests and ambitions.
Ireland is one of Canada’s closest partners in Europe, and today that relationship is flourishing. Bilateral trade has grown nearly 150% over the past decade, and Ireland is a key partner in investment, agriculture and agri-food, clean growth, and economic security. Building on that momentum, the Prime Minister, Mark Carney, today concluded a successful bilateral visit to Ireland. This marked the first visit to Ireland by a Canadian Prime Minister in nearly a decade.
In Dublin, Prime Minister Carney met with Taoiseach Martin to elevate the bilateral relationship with stronger cooperation across key sectors, guided by a new joint statement. This includes:
- Partnering on artificial intelligence (AI) by deepening cooperation and leveraging Canada’s AI for All strategy and Ireland’s new “Digital Ireland” strategy. Canada is committed to harnessing the AI revolution to seize opportunities, improve well-being, and save lives. Results are immediate, with Canada-based OpenText announcing yesterday their investment of more than $160 million in Cork, Ireland, to establish their European hub for AI.
- Strengthening resilient health systems and supply chains through collaboration on regenerative medicine, pharmaceutical manufacturing, workforce development, and biomanufacturing skills. This cooperation is reflected in the following recently signed Memoranda of Understanding (MOU):
- An MOU between the Toronto-based Centre for Commercialization of Regenerative Medicine (CCRM) and Ireland’s RINN Advanced Therapies national research centre toward exploring the establishment of a CCRM Ireland hub. This would accelerate the development and commercialisation of innovative health technologies while creating new market…
